Find a TenderAwarded without competition
Published 11 Mar 2021, 09:16 GMT

Official UK procurement notice

Trastuzumab (Herceptin®) 600mg/5ml solution for Injection

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)·Consortium: 3 public authorities

Framework agreementGoodsAward procedure without prior publication of a call for competition
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 30 Jan 2025no call for competition
Framework period 4 yrsends 31 Mar 2025 · starts 1 Apr 2021

What is being bought

Published requirement description

Supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
1 bids received · 1 suppliers appointed
Framework period
4 yrs from 1 Apr 2021

The lotProcurement structure

single lot · no lot value published
Lot #1This contract modification, effecting an extension of the Framework Agreement duration…Awarded 4 yrs

This contract modification, effecting an extension of the Framework Agreement duration from 1 April 2025 until 31 March 2026, has been agreed between the supplier and the Authority on behalf of NHS Scotland to meet the additional demands of the Scottish Health and Social Care sector.

This modification has been approved to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.

Contract period: 1 Apr 2021 – 31 Mar 2025 (4 yrs)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
11 Mar 2021, 09:16 GMT
Last source update
1 Apr 2025, 12:59 BST
Authority reference
NP91221a
FTS notice number
2025/S 000-012233
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-029a9d Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015

Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value(s) of the Framework Agreement referred to in Section V.2.4 covers the thirty (30) month contract duration and the eighteen (18) month extension period of the Framework Agreement. (SC Ref:785181)

How it was run

Official notice
Appointment period ends
—

Timeline

1 Apr 2021 → 1 Apr 2025 · 2 dates
  1. Contract starts
    1 Apr 2021, 00:00 BST
  2. Notice published
    1 Apr 2025, 12:59 BST

Notice history

2 events · 4 releases on Find a Tender · since 31 Jan 2025
  1. Buyer details updated
    31 Jan 2025, 10:21 GMT
  2. Buyer details updated
    1 Apr 2025, 12:59 BST
Routine re-releases (4)
  • 2021-03: 1 release · 11 Mar 2021

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 1admitted to the panel · see the list ↓
Bids received 1
Contracts signed 4latest 30 Jan 2025

4 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Contract 003218-2025-NP91221a-1

    Signed
    30 Jan 2025
    Value
    £4,520,506
    Period
    … – 31 Mar 2025
    Status
    active
  • Contract 016773-2021-NP91221(a)-1

    Signed
    23 Mar 2021
    Value
    £27,199,389
    Period
    … – 31 Mar 2025
    Status
    active
  • Trastuzumab (Herceptin®) 600mg/5ml solution for Injection

    Signed
    21 Mar 2021
    Value
    £22,602,530
    Period
    … – 31 Mar 2025
    Status
    active
    • Change This modification effects an extension of the Framework Agreement duration from 1 April 2025 until 31 March 2026. The modification notice is advised at Framework Agreement level only and so it does not detail individual Lots. All Terms and Conditions for the Framework Agreement remain in place., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector to maintain necessary supply due to circumstances unforeseen by the Authority, and at this time have rendered this modification necessary, in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
  • Contract 004908-2021-NP91221(a)-1

    Signed
    10 Mar 2021
    Value
    £27,141,272
    Period
    … – 31 Mar 2025
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids · 1 electronic · 1 from abroad0——

Contracting authority & participating public bodies

2 public bodies on the notice

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact email, phone

Dispute resolution & review bodies

  • Sheriff Court HouseReview body EdinburghContact email, phone

Framework contractors & participating bidders

1 commercial party on the notice
  • Roche Products LtdFramework contractor 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TWContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.